Stock listing
Genoway Sa
Selected listing: A0MRJ4 · LSX · EUR · DE
Genoway Sa (LS Exchange: A0MRJ4), Health Technology. Latest release Sep 22, 2025: GenOway : Solides résultats semestriels 2025 avec une marge d’EBITDA à 16,9%.
- Ticker
- LS Exchange: A0MRJ4
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LS Exchange
- Currency
- EUR
About Genoway Sa
The company focuses on providing innovative solutions in the field of biotechnology. Genoway is dedicated to advancing research and development in genetic engineering and related technologies.
Latest news from Genoway Sa
GenOway : Solides résultats semestriels 2025 avec une marge d’EBITDA à 16,9%
September 22, 2025
GenOway : Résultats annuels 2023
March 27, 2024
GenOway : Résultats du 1er semestre 2023
September 22, 2023
GenOway: Proposal of a new administrator
May 23, 2022
GENOWAY : A grant for €1.9 million has been awarded under the Eurostars™ programme to a consortium that comprises Abzena, Antitope, Prothix BV, Aristi Biotech BV, the University Medical Center Utrecht, and genOway
January 28, 2016
Research Genoway Sa
Alternate listings
ALGEN:EURONEXT
FR · EUR
Alternate listing for Genoway Sa; the primary context on this page is A0MRJ4:LSX.
JEH:GETTEX
DE · EUR
Alternate listing for Genoway Sa; the primary context on this page is A0MRJ4:LSX.
JEH:DUS
DE · EUR
Alternate listing for Genoway Sa; the primary context on this page is A0MRJ4:LSX.
JEH:FWB
DE · EUR
Alternate listing for Genoway Sa; the primary context on this page is A0MRJ4:LSX.
A0MRJ4:LS
DE · EUR
Alternate listing for Genoway Sa; the primary context on this page is A0MRJ4:LSX.
JEH:MUN
DE · EUR
Alternate listing for Genoway Sa; the primary context on this page is A0MRJ4:LSX.
JEH:SWB
DE · EUR
Alternate listing for Genoway Sa; the primary context on this page is A0MRJ4:LSX.
ALGENP:TURQUOISE
GB · EUR
Alternate listing for Genoway Sa; the primary context on this page is A0MRJ4:LSX.